UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 172

Sortiert nach

Bacteraemic pneumococcal pneumonia and SARS-CoV-2 pneumonia: differences and similarities

International journal of infectious diseases, 2022-02, Vol.115, p.39-47

2022

Volltextzugriff (PDF)

Community-acquired pneumonia: strategies for management

1, 2008

Volltextzugriff (PDF)

The Role of Dysbiosis in Critically Ill Patients With COVID-19 and Acute Respiratory Distress Syndrome

Frontiers in medicine, 2021-06, Vol.8, p.671714-671714

2021

Volltextzugriff (PDF)

Which individuals are at increased risk of pneumococcal disease and why? Impact of COPD, asthma, smoking, diabetes, and/or chronic heart disease on community-acquired pneumonia and invasive pneumococcal disease

Thorax, 2015-10, Vol.70 (10), p.984-989

2015

Volltextzugriff (PDF)

Cost of Hospitalizations due to Exacerbation in Patients with Non-Cystic Fibrosis Bronchiectasis

Respiration, 2018-01, Vol.96 (5), p.406-416

2018

Volltextzugriff (PDF)

Laboratory diagnosis of pneumonia in the molecular age

The European respiratory journal, 2016-12, Vol.48 (6), p.1764-1778

2016

Volltextzugriff (PDF)

Pulmonary Infection in the Immunocompromised Patient: Strategies for Management

1, 2009

Volltextzugriff (PDF)

New Sepsis Definition (Sepsis-3) and Community-acquired Pneumonia Mortality. A Validation and Clinical Decision-Making Study

American journal of respiratory and critical care medicine, 2017-11, Vol.196 (10), p.1287-1297

2017

Volltextzugriff (PDF)

Microbial Etiology of Pneumonia: Epidemiology, Diagnosis and Resistance Patterns

International journal of molecular sciences, 2016-12, Vol.17 (12), p.2120-2120

2016

Volltextzugriff (PDF)

Burden of pneumococcal community-acquired pneumonia in adults across Europe: A literature review

Respiratory medicine, 2018-04, Vol.137, p.6-13

2018

Volltextzugriff (PDF)

Severe community-acquired pneumonia: Characteristics and prognostic factors in ventilated and non-ventilated patients

PloS one, 2018-01, Vol.13 (1), p.e0191721-e0191721

2018

Volltextzugriff (PDF)

Management of severe acute exacerbations of COPD: an updated narrative review

Multidisciplinary respiratory medicine, 2018-10, Vol.13 (1), p.36-36, Article 36

2018

Volltextzugriff (PDF)

New aspects in the management of pneumonia

Critical care (London, England), 2016-10, Vol.20 (1), p.267-267, Article 267

2016

Volltextzugriff (PDF)

Inhaled amikacin for severe Gram-negative pulmonary infections in the intensive care unit: current status and future prospects

Critical care (London, England), 2018-12, Vol.22 (1), p.343-343, Article 343

2018

Volltextzugriff (PDF)

Microbial aetiology of community-acquired pneumonia and its relation to severity

Thorax, 2011-04, Vol.66 (4), p.340-346

2011

Volltextzugriff (PDF)

Advances in antibiotic therapy in the critically ill

Critical care (London, England), 2016-05, Vol.20 (1), p.133-133, Article 133

2016

Volltextzugriff (PDF)

Readmission for Acute Exacerbation within 30 Days of Discharge Is Associated with a Subsequent Progressive Increase in Mortality Risk in COPD Patients: A Long-Term Observational Study

PloS one, 2016-03, Vol.11 (3), p.e0150737-e0150737

2016

Volltextzugriff (PDF)

Acute respiratory distress syndrome in mechanically ventilated patients with community-acquired pneumonia

The European respiratory journal, 2018-03, Vol.51 (3), p.1702215-1702215

2018

Volltextzugriff (PDF)

Drugs that increase the risk of community-acquired pneumonia: a narrative review

Expert opinion on drug safety, 2018-10, Vol.17 (10), p.991-1003

2018

Volltextzugriff (PDF)

Characteristics and Management of Community-Acquired Pneumonia in the Era of Global Aging

Medical sciences (Basel), 2018-04, Vol.6 (2), p.35

2018

Volltextzugriff (PDF)

Nebulized antibiotics for ventilator-associated pneumonia: a systematic review and meta-analysis

Critical care (London, England), 2015-04, Vol.19 (1), p.150-150, Article 150

2015

Volltextzugriff (PDF)

Author’s response to ‘CAP and HCAP are different? An unresolved question

Thorax, 2014-07, Vol.69 (7), p.677-678

2014

Volltextzugriff (PDF)

Initial Inflammatory Profile in Community-acquired Pneumonia Depends on Time since Onset of Symptoms

American journal of respiratory and critical care medicine, 2018-08, Vol.198 (3), p.370-378

2018

Volltextzugriff (PDF)

Effect of Combined β-Lactam/Macrolide Therapy on Mortality According to the Microbial Etiology and Inflammatory Status of Patients With Community-Acquired Pneumonia

Chest, 2019-04, Vol.155 (4), p.795-804

2019

Volltextzugriff (PDF)

Reply to Head and Keynan

Clinical infectious diseases, 2019-04, Vol.68 (8), p.1433-1434

2019

Volltextzugriff (PDF)

1 – 25 von 172

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(162)
Mit Volltextzugriff
(158)

Publikationsform

Sprache

Englisch
(151)
Spanisch
(21)
Japanisch
(10)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Plos One
(17)
Critical Care Medicine
(12)
Archivos De Bronconeumología
(11)
Critical Care
(11)
Thorax
(9)
Respiratory Research
(6)
The European Respiratory Journal
(6)
Chest
(5)
Respiratory Care
(5)
Clinical Chemistry And Laboratory Medicine
(4)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Bacteraemic pneumococcal pneumonia and SARS-CoV-2 pneumonia: differences and similarities

Community-acquired pneumonia: strategies for management

The Role of Dysbiosis in Critically Ill Patients With COVID-19 and Acute Respiratory Distress Syndrome

Which individuals are at increased risk of pneumococcal disease and why? Impact of COPD, asthma, smoking, diabetes, and/or chronic heart disease on community-acquired pneumonia and invasive pneumococcal disease

Cost of Hospitalizations due to Exacerbation in Patients with Non-Cystic Fibrosis Bronchiectasis

Laboratory diagnosis of pneumonia in the molecular age

Pulmonary Infection in the Immunocompromised Patient: Strategies for Management

New Sepsis Definition (Sepsis-3) and Community-acquired Pneumonia Mortality. A Validation and Clinical Decision-Making Study

Microbial Etiology of Pneumonia: Epidemiology, Diagnosis and Resistance Patterns

Burden of pneumococcal community-acquired pneumonia in adults across Europe: A literature review

Severe community-acquired pneumonia: Characteristics and prognostic factors in ventilated and non-ventilated patients

Management of severe acute exacerbations of COPD: an updated narrative review

New aspects in the management of pneumonia

Inhaled amikacin for severe Gram-negative pulmonary infections in the intensive care unit: current status and future prospects

Microbial aetiology of community-acquired pneumonia and its relation to severity

Advances in antibiotic therapy in the critically ill

Readmission for Acute Exacerbation within 30 Days of Discharge Is Associated with a Subsequent Progressive Increase in Mortality Risk in COPD Patients: A Long-Term Observational Study

Acute respiratory distress syndrome in mechanically ventilated patients with community-acquired pneumonia

Drugs that increase the risk of community-acquired pneumonia: a narrative review

Characteristics and Management of Community-Acquired Pneumonia in the Era of Global Aging

Nebulized antibiotics for ventilator-associated pneumonia: a systematic review and meta-analysis

Author’s response to ‘CAP and HCAP are different? An unresolved question

Initial Inflammatory Profile in Community-acquired Pneumonia Depends on Time since Onset of Symptoms

Effect of Combined β-Lactam/Macrolide Therapy on Mortality According to the Microbial Etiology and Inflammatory Status of Patients With Community-Acquired Pneumonia

Reply to Head and Keynan

Suchergebnisse filtern